We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

QPharma, Inc. Launches qSpend™

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute
QPharma, Inc., has announced the official release of their aggregate spend solution, qSpend™. This tool assists Pharmaceutical, Biotechnology, and Medical Device companies in complying with countless state and federal laws, regulations, and industry guidelines governing sales and marketing. qSpend is QPharma’s cost-efficient, aggregate spend solution for tracking, evaluating, and reporting sales and marketing expenditures in a regulatory compliant manner.

“Companies face many challenges in the implementation and adaptation of their aggregate spend solution in this evolving regulatory landscape. qSpend was developed to ensure compliance with the regulatory requirements while creating a flexible, sustainable model moving into the future.”

qSpend is a Web-based solution available on-demand to provide access anytime, anywhere. The solution provides several means for capturing expense data including manual data entry, file uploads, and third party expense management system interfaces. qSpend is fully configurable and includes customer-specific administrative preferences, thresholds, and alerts. The system complies with both state and federal reporting requirements generating these reports with the simple click of a button. The qSpend solution is available as software on demand or as a fully outsourced service.

Alexis Stroud, Manager of Regulatory Compliance, stated, “Companies face many challenges in the implementation and adaptation of their aggregate spend solution in this evolving regulatory landscape. qSpend was developed to ensure compliance with the regulatory requirements while creating a flexible, sustainable model moving into the future.”